DGAP-Ad-hoc: EXASOL AG / Key word(s): Capital Increase 
EXASOL SUCCESSFULLY PLACES 2.2 MILLION NEW SHARES FROM CASH CAPITAL INCREASE 
WITH GROSS PROCEEDS OF EUR 43.3 MILLION 
 
02-Dec-2020 / 22:57 CET/CEST 
Disclosure of an inside information acc. to Article 17 MAR of the Regulation 
(EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) DIRECTLY 
OR INDIRECTLY IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR 
JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION 
OF THE RELEVANT LAWS OF SUCH JURISDICTION. 
 
*EXASOL SUCCESSFULLY PLACES 2.2 MILLION NEW SHARES FROM CASH CAPITAL 
INCREASE WITH GROSS PROCEEDS OF EUR 43.3 MILLION* 
 
*Nuremberg, Germany, 2 December 2020* - Exasol AG ("Exasol" or the 
"Company", ISIN DE000A0LR9G9, Frankfurt Stock Exchange, Ticker symbol EXL, 
www.exasol.com) announces that a capital increase of 10 percent of the share 
capital (the "*Capital Increase*") has been fully placed. 
 
The Management Board of Exasol, with approval of the Supervisory Board, 
resolved today to increase the Company's share capital by way of a partial 
exercise of authorized capital under exclusion of shareholders' subscription 
rights by EUR 2,221,000.00 by issuing 2,221,000 new ordinary registered 
shares with no-par value _(Stückaktien)_, each with a notional value of EUR 
1.00, against cash contributions (the "*New Shares*"). 
 
The Capital Increase was oversubscribed within 45 minutes of launch, which 
enabled the bookbuilding to close after only after a few hours. 
 
All New Shares were allocated at a placement price of EUR 19.5 per share in 
a private placement by way of an accelerated bookbuilding. The transaction 
generated gross issue proceeds of EUR 43.3 million for Exasol. 
 
The New Shares will carry the same rights as the existing shares (including 
dividend rights for the fiscal year 2020) and are to be included in trading 
on the European SME Growth Market "Scale" of the Frankfurt Stock Exchange 
without a prospectus. The inclusion in trading and delivery of the new 
shares is expected to take place on or around 8 December 2020. 
 
In connection with the Capital Increase, the Company has agreed to a lock-up 
period of 6 months with customary exceptions. 
 
The Company intends to use the net proceeds from the Capital Increase to 
visibly strengthen the balance sheet to underline its robust growth strategy 
and to accelerate international growth through key hires. 
 
Hauck & Aufhäuser acted as Sole Global Coordinator and Sole Bookrunner in 
the Capital Increase. 
 
## 
 
*Exasol Investor Relations contact* 
 
Jochen Reichert, +49 911 23991 454 
jochen.reichert@exasol.com 
 
Stefanie Winkler, +49 911 23991 298 
stefanie.winkler@exasol.com 
 
*IMPORTANT NOTE* 
 
This announcement does not contain or constitute or form part of, and should 
not be construed as, an offer or invitation to sell, or the solicitation of 
an offer to buy or subscribe for, any securities of Exasol AG. In connection 
with the Capital Increase there has not been, nor will there be, any public 
offering of the New Shares. 
 
The distribution of this announcement and the offer and sale of the 
securities referred to herein may be restricted by law in certain 
jurisdictions, and persons reading this announcement should inform 
themselves about and observe any such restrictions. Any failure to comply 
with these restrictions may constitute a violation of the securities laws of 
any such jurisdiction. 
 
This announcement and the information contained herein are not for 
distribution in or into the United States of America (including its 
territories and possessions, any state of the United States of America and 
the District of Columbia) (the "*United States*"), Australia, Canada or 
Japan. This announcement does not constitute, or form part of, an offer to 
sell, or a solicitation of an offer to purchase, any securities of Exasol AG 
in the United States. The New Shares have not been and will not be 
registered under the U.S. Securities Act of 1933, as amended (the 
"*Securities Act*"), and may not be offered or sold within the United States 
absent registration or an applicable exemption from, or in a transaction not 
subject to, the registration requirements of the Securities Act. Exasol AG 
does not intend to conduct a public offering of securities in the United 
States. Any sale in the United States of the securities mentioned in this 
announcement will be made solely to _qualified institutional buyers_ as 
defined in Rule 144A under the Securities Act. 
 
In the United Kingdom, this announcement is directed at and/or for 
distribution only to (i) investment professionals falling within article 
19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) 
Order 2005, as amended (the "*Order*"), or (ii) high net worth companies 
falling within article 49(2)(a) to (d) of the Order (all such persons are 
collectively referred to herein as "*relevant persons*"). The New Shares are 
only available to, and any invitation, offer or agreement to subscribe, 
purchase or otherwise acquire such securities will be engaged in only with, 
relevant persons. Any person who is not a relevant person should not act or 
rely on this announcement or any of its contents. 
 
In member states of the European Economic Area ("*EEA*") in which the 
Regulation (EU) 2017/1129, as amended (the "*Prospectus Regulation*"), is in 
effect, other than Germany and the United Kingdom (the "*Relevant Member 
States*"), this announcement, and any offer following it, is only addressed 
to persons who are _qualified investors_ within the meaning of Article 2(e) 
of the Prospectus Regulation ("*Qualified Investors*"). It is assumed that 
each person in the Relevant Member States who acquires or is offered New 
Shares as part of an offering (an "*Investor*") has represented and agreed 
that such person is a Qualified Investor; that New Shares purchased by such 
person as part of the offering are not being purchased for any person in the 
EEA other than a Qualified Investor or persons in Germany, the United 
Kingdom or another Relevant Member State with comparable legal provisions, 
with respect to whom the Investor may make decisions at its own discretion; 
and that the New Shares would not be purchased for offer or re-sale in the 
EEA, if this would lead to Exasol AG or any of its affiliates being required 
to publish a prospectus under Article 3 of the Prospectus Regulation. 
 
02-Dec-2020 CET/CEST The DGAP Distribution Services include Regulatory 
Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
Language:    English 
Company:     EXASOL AG 
             Neumeyerstraße 22-26 
             90411 Nuremberg 
             Germany 
Internet:    www.exasol.com 
ISIN:        DE000A0LR9G9 
WKN:         A0LR9G 
Listed:      Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt 
             (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID: 1152432 
 
End of Announcement DGAP News Service 
 
1152432 02-Dec-2020 CET/CEST 
 
 

(END) Dow Jones Newswires

December 02, 2020 16:57 ET (21:57 GMT)